We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Celtic Pharma Announces Results of a Phase III Program Evaluating XERECEPT® in Brain Tumors

News   Jun 08, 2009

 
Celtic Pharma Announces Results of a Phase III Program Evaluating XERECEPT® in Brain Tumors
 
 
 

RELATED ARTICLES

Shoulder Pain Relief for Wheelchair Users With Spinal Cord Injury

News

Researchers report initial results for a minimally invasive intervention for relief of chronic refractory shoulder pain in upper-limb dependent individuals with spinal cord injury.

READ MORE

Popeye’s Spinach Prophecy Was Right: Low Vitamin K Linked to Poor Mobility

News

Low levels of circulating vitamin K are linked to increased risk of mobility limitation and disability in older adults, identifying a new factor to consider for maintaining mobility and independence in older age, according to a study.

READ MORE

Aging in Older Mice Delayed by Giving Enzyme From Younger Mice

News

New research has identified a novel approach to staving off the detrimental effects of aging in mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE